Skip to main content
Clinical Trials/NCT03596775
NCT03596775
Unknown
Early Phase 1

Effect of Single-dose Dexmedetomidine on Emergence Agitation and Postoperative Behavior Changes After Sevoflurane Anesthesia in Children

Xuzhou Medical University1 site in 1 country96 target enrollmentStarted: September 1, 2018Last updated:

Overview

Phase
Early Phase 1
Sponsor
Xuzhou Medical University
Enrollment
96
Locations
1
Primary Endpoint
Incidence of EA as assessed by the Pediatric Anesthesia Emergence Delirium (PAED) scale

Overview

Brief Summary

Emergence agitation (EA) is a dissociated state of consciousness in which the child is inconsolable, irritable, uncooperative, typically thrashing, crying, moaning, or incoherent. Although usually transient, it is not only an extremely distressing event for children, parents, and staff, but may also result in self-injury or the need for restraint. The prevalence in children appears to be between 10% and 80% depending upon the definition and measurement tools used and is more frequently observed in the pre-school age-group. A clear correlation has been found between EA and negative postoperative behavioral changes, including anxiety, eating and sleeping disorders, enuresis, fear of darkness, that may persist for an extended period of time affecting emotional and cognitive development.Currently, numerous interventions have been studied to manage EA after surgery. Among them, dexmedetomidine (DEX) as a kind of highly selective α2 adrenergic receptor agonist has been done to reduce EA in children. Unfortunately, no studies examined posthospitalization negative behaviour changes.

Detailed Description

The high incidence of EA and postoperative behavioural changes has encouraged paediatric anaesthetists and researchers to study methods to improve the perioperative care of children. Dexmedetomidine is a selective alpha-2 receptor agonist with properties that make it attractive to pediatric use. It provides sedation and anxiolysis acting on these receptors in the locus ceruleus of the pons. It also exerts dose-dependent moderate primary analgesic effects through activation of alpha-2 adrenoreceptors in the dorsal spinal horn causing a subsequent decrease in substance P release. The study aims to explore whether a single low-dose dexmedetomidine in the perioperative period has a preventive effect on EA in children, and through short-term and long-term follow-up, to investigate the effect on post-hospitalization behavioural changes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
2 Years to 7 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age between 2-7 years old
  • American Society of Anesthesiologists(ASA) score of I or II
  • Selective ear, nose, and throat surgery under general anaesthesia with sevoflurane

Exclusion Criteria

  • Emergency surgery
  • were intubated before induction of anaesthesia or not planned for extubation after anaesthesia
  • had critical illness with haemodynamic instability, active bleeding, cancer, cardiac diseases including arrhythmias, malignant hyperthermia
  • intellectual disability, or neurological illness with agitation-like symptoms
  • weighed more than 50 kg
  • were allergic to dexmedetomidine
  • The use of sedative or analgesic medications before surgery

Arms & Interventions

Dexmedetomidine group

Experimental

the children received 0.5 μg/kg of intravenous dexmedetomidine over 10 minutes after induction of anesthesia

Intervention: Dexmedetomidine (Drug)

Control Comparator group

Placebo Comparator

the children received 10ml saline over 10 minutes after induction of anesthesia

Intervention: saline (Drug)

Outcomes

Primary Outcomes

Incidence of EA as assessed by the Pediatric Anesthesia Emergence Delirium (PAED) scale

Time Frame: within 30 minutes after extubation in the post-anaesthesia care unit

Use the Pediatric Anesthesia Emergence Delirium (PAED) scale to record the incidence of EA.The score ranges from 0 to 20 points. A score of 10 or above is considered as EA.

Secondary Outcomes

  • Pain scores as assessed by the Face, Legs, Activity, Cry, Consolability (FLACC) scale(within 30 minutes after extubation in the post-anaesthesia care unit)
  • Rescue analgesia and sedative drug consumption(within 30 minutes after extubation in the post-anaesthesia care unit)
  • Incidence of adverse events(within 30 minutes after extubation in the post-anaesthesia care unit)
  • Post-hospitalization negative behaviour changes as assessed by the Post Hospitalisation Behaviour Questionnaire (PHBQ) scale(1 day, 2 days,30 days post surgery)

Investigators

Sponsor
Xuzhou Medical University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jin Dong Liu

Principal Investigator

Xuzhou Medical University

Study Sites (1)

Loading locations...

Similar Trials